CASGEVY
CASGEVY was the first gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia.
It is a transformative treatment that offers the power of a stem cell transplant without the need for a donor.
The “Be IN” patient campaign featured real people with SCD and TDT, along with vibrant "IN-words,” capturing the potential of life after CASGEVY.
And here is a sample of how that campaign was implemented across patient materials.
Patient Brochures
Patient Testimonial Videos
Patient Website
Supplementary Brochures Contextualizing the Treatment Journey
MOA Video
Gene therapy is complicated and could be confusing to patients, especially ones as young as 12 years old. This video was designed to demystify the process.
The HCP campaign, featured here in its interactive visual aid implementation, showcases the transformative power of the one-time precision gene-editing of CASGEVY.
Leave Behind
Treatment Journey Brochure
Patient Discussion Guide…
Treatment Guide for Non-prescribing Clinical Staff
…and accompanying FAQs
